CADM2 has been reported to be a tumor suppressor in hepatocellular carcinoma and in glioma [31,32], and has been shown to inhibit the migration and invasion of tumor cells via the FAK/AKT signaling pathway [31]. This evidence concerns the gene PTK2 and hepatocellular carcinoma.